Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leu, Y.-W.
Right arrow Articles by Huang, T. H.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leu, Y.-W.
Right arrow Articles by Huang, T. H.-M.
[Cancer Research 63, 6110-6115, October 1, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Double RNA Interference of DNMT3b and DNMT1 Enhances DNA Demethylation and Gene Reactivation1

Yu-Wei Leu, Farahnaz Rahmatpanah, Huidong Shi, Susan H. Wei, Joseph C. Liu, Pearlly S. Yan and Tim Hui-Ming Huang2

Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210 [Y-W. L., S. H. W., J. C. L., P. S. Y., T. H-M. H.], and Department of Pathology and Anatomical Sciences, Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, Missouri 65203 [F. R., H. S.]

Small interfering RNAs (siRNAs) are newly identified molecules shown to silence genes via targeted mRNA degradation. In this study, we used specific siRNAs as a tool to probe the relationship between two DNA methyltransferase genes, DNMT3b and DNMT1, in the maintenance of DNA methylation patterns in the genome. Levels of DNMT3b or DNMT1 mRNAs and proteins were markedly decreased (up to 80%) on transfecting these siRNAs into the ovarian cancer cell line CP70. The resulting RNA interference showed differential effects on DNA demethylation and gene reactivation in the treated cells. The DNMT1 siRNA treatment led to a partial removal of DNA methylation from three inactive promoter CpG islands, TWIST, RASSF1A, and HIN-1, and restored the expression of these genes. This epigenetic alteration appeared less effective in cells transfected with DNMT3b siRNA. However, the combined treatment of DNMT3b and DNMT1 siRNAs greatly enhanced this demethylation effect, producing 7–15-fold increases in their expression. We also used a microarray approach to examine this RNA interference on 8640 CpG island loci in CP70 cells. The combined siRNA treatment had a greater demethylation effect on 241 methylated loci and selected repetitive sequences than that of the single treatment. Our data thus suggest that whereas DNMT1 plays a key role in methylation maintenance, DNMT3b may act as an accessory to support the function in CP70 cells. This study also shows that siRNA is a powerful tool for interrogating the mechanisms of DNA methylation in normal and pathological genomes.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Balch, F. Fang, D. E. Matei, T. H.-M. Huang, and K. P. Nephew
Minireview: Epigenetic Changes in Ovarian Cancer
Endocrinology, September 1, 2009; 150(9): 4003 - 4011.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Nosho, K. Shima, N. Irahara, S. Kure, Y. Baba, G. J. Kirkner, L. Chen, S. Gokhale, A. Hazra, D. Spiegelman, et al.
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Clin. Cancer Res., June 1, 2009; 15(11): 3663 - 3671.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kundakovic, Y. Chen, A. Guidotti, and D. R. Grayson
The Reelin and GAD67 Promoters Are Activated by Epigenetic Drugs That Facilitate the Disruption of Local Repressor Complexes
Mol. Pharmacol., February 1, 2009; 75(2): 342 - 354.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. J. Dudley, K. Revill, P. Whitby, R. N. Clayton, and W. E. Farrell
Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary Tumors
Mol. Cancer Res., October 1, 2008; 6(10): 1567 - 1574.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
F. Spada, A. Haemmer, D. Kuch, U. Rothbauer, L. Schermelleh, E. Kremmer, T. Carell, G. Langst, and H. Leonhardt
DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells
J. Cell Biol., February 26, 2007; 176(5): 565 - 571.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Wu, Q. C.-K. Cheung, L. Wen, and J. Li
A Growth-Maturation System That Enhances the Meiotic and Developmental Competence of Porcine Oocytes Isolated from Small Follicles
Biol Reprod, October 1, 2006; 75(4): 547 - 554.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Egger, S. Jeong, S. G. Escobar, C. C. Cortez, T. W. H. Li, Y. Saito, C. B. Yoo, P. A. Jones, and G. Liang
Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival
PNAS, September 19, 2006; 103(38): 14080 - 14085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, G. Walsh, D. D. Liu, J. J. Lee, and L. Mao
Expression of {Delta}DNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non-Small Cell Lung Cancer.
Cancer Res., September 1, 2006; 66(17): 8361 - 8366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Loriot, E. De Plaen, T. Boon, and C. De Smet
Transient Down-regulation of DNMT1 Methyltransferase Leads to Activation and Stable Hypomethylation of MAGE-A1 in Melanoma Cells
J. Biol. Chem., April 14, 2006; 281(15): 10118 - 10126.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Ting, K.-w. Jair, K. E. Schuebel, and S. B. Baylin
Differential Requirement for DNA Methyltransferase 1 in Maintaining Human Cancer Cell Gene Promoter Hypermethylation
Cancer Res., January 15, 2006; 66(2): 729 - 735.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. W. Laird
Cancer epigenetics
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R65 - R76.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Sung, J. Turner, S. McCarthy, S. Enkemann, C. G. Li, P. Yan, T. Huang, and T. J. Yeatman
Oncogene regulation of tumor suppressor genes in tumorigenesis
Carcinogenesis, February 1, 2005; 26(2): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
DNA ResHome page
L. R. Vasques, R. Stabellini, F. Xue, X. C. Tian, M. Soukoyan, and L. V. Pereira
XIST Repression in the Absence of DNMT1 and DNMT3B
DNA Res, January 1, 2005; 12(5): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Gorbunova, A. Seluanov, D. Mittelman, and J. H. Wilson
Genome-wide demethylation destabilizes CTG{middle dot}CAG trinucleotide repeats in mammalian cells
Hum. Mol. Genet., December 1, 2004; 13(23): 2979 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Yu and B. C. Kone
Hypermethylation of the Inducible Nitric-oxide Synthase Gene Promoter Inhibits Its Transcription
J. Biol. Chem., November 5, 2004; 279(45): 46954 - 46961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.